Clinical Trials for Drug: MRG-106

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-16-46 A Phase 1 dose-ranging study to investigate the safety, tolerability and pharmacokinetics of MRG-106 following local intratumoral, subcutaneous, and intravenous administration in subjects with various lymphomas and leukemias Open